$0.6168
-0.062-9.13%
最終更新: Oct 30, 4:55 AM
Benzinga
Benzinga
Benzinga
金曜日, 10 30
Benzinga
© 2026 Benzinga | All Rights Reserved
Valion Bio (VBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-54.25 | $-55.75 | $-37.25 | $-50.00 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $80000 | $146000 |
| Surprise | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q3 | Nov 14, 2023 | $-629.00 | $-2.98K | 78.9 % |
| Q2 | Aug 14, 2023 | $-2.98K | $-3.40K | 12.5 % |
| Q1 | May 15, 2023 | $-4.68K | $-4.68K | 0.00 % |
| Q4 | Mar 31, 2023 | $-9.78K | $-13.18K | 25.8 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q3 | Nov 14, 2023 | $282.00K | $780.00K | -63.8 % |
| Q2 | Aug 14, 2023 | $161.00K | $630.00K | -74.4 % |
| Q1 | May 15, 2023 | $376.00K | $520.00K | -27.7 % |
| Q4 | Mar 31, 2023 | $408.00K | $640.00K | -36.3 % |